Drugs / Long-Acting Methylphenidate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00783835 | Feb → Oct 2008 | attention deficit-hyperactivity disorder | Janssen-Cilag Farmaceutica Ltda. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Long-Acting Methylphenidate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00783835 ↗ |
| Route | Oral | “will be orally administered” NCT00783835 ↗ |